Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Evolocumab biosimilar by Cinnagen for Hyperlipidemia: Likelihood of Approval
Evolocumab biosimilar is under clinical development by Cinnagen and currently in Phase III for Hyperlipidemia. According to GlobalData, Phase III...